These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22761158)

  • 21. [Hoigne syndrome following an intravenous injection of ceftriaxone: a case report].
    Landais A; Marty N; Bessis D; Pages M; Blard JM
    Rev Med Interne; 2014 Mar; 35(3):199-201. PubMed ID: 23541140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased adverse drug reactions to cephalosporins in penicillin allergy patients with positive penicillin skin test.
    Park MA; Koch CA; Klemawesch P; Joshi A; Li JT
    Int Arch Allergy Immunol; 2010; 153(3):268-73. PubMed ID: 20484925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study.
    Roberts JA; Boots R; Rickard CM; Thomas P; Quinn J; Roberts DM; Richards B; Lipman J
    J Antimicrob Chemother; 2007 Feb; 59(2):285-91. PubMed ID: 17135183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaphylactic deaths in Maryland (United States) and Shanghai (China): a review of forensic autopsy cases from 2004 to 2006.
    Shen Y; Li L; Grant J; Rubio A; Zhao Z; Zhang X; Zhou L; Fowler D
    Forensic Sci Int; 2009 Apr; 186(1-3):1-5. PubMed ID: 19217731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of drug safety information using large-scale adverse drug reactions database].
    Morikawa K
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2011; (129):1-26. PubMed ID: 22259840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clindamycin skin testing has limited diagnostic potential.
    Notman MJ; Phillips EJ; Knowles SR; Weber EA; Shear NH
    Contact Dermatitis; 2005 Dec; 53(6):335-8. PubMed ID: 16364122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical adverse effects during ceftriaxone therapy.
    Moskovitz BL
    Am J Med; 1984 Oct; 77(4C):84-8. PubMed ID: 6093526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug associated hepatic reactions in New Zealand: 21 years experience.
    Pillans PI
    N Z Med J; 1996 Aug; 109(1028):315-9. PubMed ID: 8816722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiocontrast anaphylaxis with failure of premedication.
    Worthley DL; Gillis D; Kette F; Smith W
    Intern Med J; 2005 Jan; 35(1):58-60. PubMed ID: 15667471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The comparison of single-dose ceftriaxone, five-day azithromycin, and ten-day amoxicillin/clavulanate for the treatment of children with acute otitis media.
    Biner B; Celtik C; Oner N; Küçükuğurluoğlu Y; Güzel A; Yildirim C; Adali MK
    Turk J Pediatr; 2007; 49(4):390-6. PubMed ID: 18246740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.
    Dinesh D; Dugan N; Carter J
    Intern Med J; 2008 Jun; 38(6):438-41. PubMed ID: 18613898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective study of antimicrobial-related adverse drug reactions in hospitalized patients.
    Sun HY; Chen YC; Wang YW; Gau CS; Chang SC
    J Microbiol Immunol Infect; 2008 Apr; 41(2):151-9. PubMed ID: 18473103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diplopia and fluoroquinolones.
    Fraunfelder FW; Fraunfelder FT
    Ophthalmology; 2009 Sep; 116(9):1814-7. PubMed ID: 19643481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced liver injury associated with high-dose ceftriaxone: a retrospective cohort study adjusted for the propensity score.
    Nakaharai K; Sakamoto Y; Yaita K; Yoshimura Y; Igarashi S; Tachikawa N
    Eur J Clin Pharmacol; 2016 Aug; 72(8):1003-11. PubMed ID: 27126206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful desensitisation to ceftriaxone in a patient with doxycicline resistant Lyme disease.
    Rodrigues J; Cruz LG; Botelho C; Rio E; Castel-Branco MG
    Allergol Immunopathol (Madr); 2009; 37(2):105-6. PubMed ID: 19445868
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety of ceftriaxone sodium at extremes of age.
    Monte SV; Prescott WA; Johnson KK; Kuhman L; Paladino JA
    Expert Opin Drug Saf; 2008 Sep; 7(5):515-23. PubMed ID: 18759704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A report of near fatal ceftriaxone induced anaphylaxis in a child with review of literature.
    Shrestha D; Dhakal AK; Shakya H; Shah SC; Shakya A
    Nepal Med Coll J; 2013 Mar; 15(1):84-6. PubMed ID: 24592804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceftriaxone-induced immune hemolytic anemia.
    Neuman G; Boodhan S; Wurman I; Koren G; Bitnun A; Kirby-Allen M; Ito S
    Ann Pharmacother; 2014 Dec; 48(12):1594-604. PubMed ID: 25163809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypersensitivity due to ceftriaxone mimicking measles in a child.
    Arulraj R; Venkatesh C; Chhavi N; Soundararajan P
    Indian J Pharmacol; 2013; 45(5):528-9. PubMed ID: 24130394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.